<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To further investigate the potential clinical significance of Y chromosome loss as the sole bone marrow karyotype change, we studied 161 Mayo Clinic male patients with 75% or more metaphase cells with Y loss, and correlated the percent Y loss with age and hematopathologic review </plain></SENT>
<SENT sid="1" pm="."><plain>In patients with a lymphoproliferative or <z:e sem="disease" ids="C1136084" disease_type="Neoplastic Process" abbrv="">plasma cell disorder</z:e>, the negligible proportion of bone marrow involvement cannot account for the observed high proportion of -Y cells </plain></SENT>
<SENT sid="2" pm="."><plain>In males with myeloid disease, Y loss appears to often represent the abnormal myeloid clone, which may also harbor acquired genetic changes that are not observed by conventional cytogenetic analysis </plain></SENT>
</text></document>